Stay updated on Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page
- Check2 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top element was removed. No other substantive changes.SummaryDifference0.7%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.7%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference24%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the revision number from v2.16.11 to v2.16.12. Additionally, the date has been updated from 2025-02-06 to 2025-08-13.SummaryDifference2%
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.